Delivery Order SPE2DB25D3402-SPE2DB25FUGCV
Award Date
4/25/25
Potential Completion Date
5/16/25
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,881.36, is a delivery order for the medication XOLAIR 150 MG/ML SYRINGE. The contract is a firm fixed-price, non-set-aside award with a performance period through May 9, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $4,622.70 for the supply of XOLAIR 150 MG/ML autoinjector medication. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has a firm fixed price pricing structure with a completion date of May 3, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $8,342.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XOLAIR 150 MG/1.2 ML POWDER VLS medication. The contract is a Firm Fixed Price Delivery Order with a performance period through May 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order for the supply of XOLAIR 150 mg/mL autoinjectors, with a ceiling value of $8,475.96 and a period of performance through April 17, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,679.36 firm fixed-price delivery order (SPE2DX15D6028|SPE2DX25FWJAV) is for the supply of XOLAIR 150MG VIAL 1S and has an ultimate completion date of March 12, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,762.72 contract is for the supply of 150 mg/mL syringes of the biologic medication Xolair. The order has a performance period through May 14, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for federal...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xolair 150 mg/1.2 ml powder, a medication used to treat certain respiratory conditions. The contract has a ceiling value of $5,005.50 and is a firm fixed-price, non-set-aside contract with a period of performance through May 14, 2025. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp., a major pharmaceutical distribution company. The $38,522.50 firm-fixed-price contract is for the supply of XOLAIR 150 MG/ML autoinjectors, with a completion date of May 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 mg/ml syringes. The award, valued at $11,605.50, has an ultimate completion date of April 16, 2024. This order is part of a larger indefinite delivery vehicle (IDV) contract, number 4600082013 under the SPE2DB program, with a ceiling value of up to $4,999,999 through 2025. Under this IDV, DMS Pharmaceutical Group...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order from the Defense Logistics Agency (DLA) valued at $1,450.71. The contract is for the delivery of 4567692576 Allergy Relief 180 mg Tablets. It is a firm-fixed price contract with a completion date of March 26, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...